Intensity Therapeutics, Inc.
INTS
$4.04
$0.020.50%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -23.54% | 20.22% | -14.23% | -5.28% | 24.20% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | -13.79% | -4.19% | -26.73% | 47.62% |
| Change in Net Operating Assets | 27.57% | 10.88% | 200.00% | 66.14% | -162.16% |
| Cash from Operations | -28.15% | 23.95% | -0.59% | 2.81% | -23.48% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 972.61% | -97.99% | 3.73% | 61.23% | 1,255.36% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -757.14% | 98.76% | -87.71% | 67.74% | -5,388.24% |
| Cash from Financing | 982.67% | -97.93% | 0.23% | 93.37% | 1,041.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 57.28% | -134.53% | 0.06% | 276.92% | 177.48% |